Obsessive Compulsive Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Obsessive Compulsive Disorder stocks.

Obsessive Compulsive Disorder Stocks Recent News

Date Stock Title
May 21 LLY Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
May 21 LLY IBD Stock Of The Day Eli Lilly Breaks Out On Its Way To A Record High
May 21 LLY If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today
May 21 LLY Lilly partners with Aktis, deepening radiopharma investment
May 21 LLY Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds
May 21 LLY Eli Lilly inks radiopharma deal worth up to $1.1B with Aktis
May 21 ALKS Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
May 21 LLY More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure
May 21 LLY Eli Lilly’s tirzepatide cleared for diabetes treatment in China
May 21 LLY Eli Lilly's diabetes drug tirzepatide gets approval in China
May 21 MDT Medtronic heads into earnings having seen rivals prosper
May 20 MDT Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
May 20 MDT MiniMed™ 780G system recognized among Fast Company's 2024 World Changing Ideas
May 20 MDT Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
May 20 MDT Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
May 20 MDT EuroPCR: Medtronic Evolut™ TAVR Platform Demonstrates Improved Quality of Life for Women with Severe Aortic Stenosis
May 20 LLY Magnificent Seven? Just Two Members Clear This Bar
May 20 LLY The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
May 20 MDT Medtronic reports positive results from Affera system trial
May 20 LLY The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Obsessive Compulsive Disorder

Obsessive–compulsive disorder (OCD) is a mental disorder where people feel the need to check things repeatedly, perform certain routines repeatedly (called "rituals"), or have certain thoughts repeatedly (called "obsessions"). People are unable to control either the thoughts or the activities for more than a short period of time. Common activities include hand washing, counting of things, and checking to see if a door is locked. Some may have difficulty throwing things out. These activities occur to such a degree that the person's daily life is negatively affected. This often takes up more than an hour a day. Most adults realize that the behaviors do not make sense. The condition is associated with tics, anxiety disorder, and an increased risk of suicide.The cause is unknown. There appear to be some genetic components with both identical twins more often affected than both non-identical twins. Risk factors include a history of child abuse or other stress-inducing event. Some cases have been documented to occur following infections. The diagnosis is based on the symptoms and requires ruling out other drug related or medical causes. Rating scales such as the Yale–Brown Obsessive Compulsive Scale (Y-BOCS) can be used to assess the severity. Other disorders with similar symptoms include anxiety disorder, major depressive disorder, eating disorders, tic disorders, and obsessive–compulsive personality disorder.Treatment involves counseling, such as cognitive behavioral therapy (CBT), and sometimes antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or clomipramine. CBT for OCD involves increasing exposure to what causes the problems while not allowing the repetitive behavior to occur. While clomipramine appears to work as well as SSRIs, it has greater side effects so is typically reserved as a second line treatment. Atypical antipsychotics may be useful when used in addition to an SSRI in treatment-resistant cases but are also associated with an increased risk of side effects. Without treatment, the condition often lasts decades.Obsessive–compulsive disorder affects about 2.3% of people at some point in their life. Rates during a given year are about 1.2%, and it occurs worldwide. It is unusual for symptoms to begin after the age of 35, and half of people develop problems before 20. Males and females are affected about equally. In English, the phrase obsessive–compulsive is often used in an informal manner unrelated to OCD to describe someone who is excessively meticulous, perfectionistic, absorbed, or otherwise fixated.

Browse All Tags